Deutsch English Français

Contact

EP2640405

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2640405

EP2640405 - HUMAN-ADAPTED HA POLYPEPTIDES, VACCINES, AND INFLUENZA TREATMENT [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 01.09.2017 Database last updated on 16.09.2024
Former	Examination is in progress Status updated on 23.12.2016
Most recent event Tooltip	01.09.2017	Application deemed to be withdrawn	published on 04.10.2017 [2017/40]
Applicant(s)	For all designated states Massachusetts Institute of Technology 77 Massachusetts Avenue Cambridge MA 02142 / US
	[N/P]
Former [2013/39]	For all designated states Massachusetts Institute of Technology 77 Massachusetts Avenue Cambridge, MA 02142 / US
Inventor(s)	01 / RAMAN, Rahul 132 Clocktower Drive Unit 311 Waltham, MA 02452 / US
	02 / KOH, Xiaoying 56 Webster Avenue Cambridge, MA 02141 / US
	03 / VISWANATHAN, Karthik 3114 Stearns Hill Road Waltham, MA 02451 / US
	04 / SASISEKHARAN, Ram 4 Duval Way Bedford, MA 01730 / US
	05 / CHANDRASEKARAN, Aarthi 243 Buena Vista Avenue, 902 Sunnyvale, CA 94086 / US
	[2013/39]
Representative(s)	Cornish, Kristina Victoria Joy, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB
	[N/P]
Former [2013/39]	Cornish, Kristina Victoria Joy, et al Kilburn & Strode LLP 20 Red Lion Street London WC1R 4PJ / GB
Application number, filing date	11827500.7	21.09.2011
	WO2011US52670
Priority number, date	US20100384780P	21.09.2010 Original published format: US 384780 P
	[2013/39]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2012040406
	Date:	29.03.2012
	Language:	EN
	[2012/13]
	Type:	A2 Application without search report
	No.:	EP2640405
	Date:	25.09.2013
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 29.03.2012 takes the place of the publication of the European patent application.
	[2013/39]
Search report(s)	International search report - published on:	US	09.08.2012
	(Supplementary) European search report - dispatched on:	EP	13.03.2015
Classification	IPC:	A61K38/00, C07K1/00, C12P21/06, C40B40/12, C07K14/005, A61K39/12, A61K39/145	[2015/16]
	CPC:	C07K14/005 (EP,US); A61K39/12 (US); A61K39/145 (US); A61P31/16 (EP); A61P37/04 (EP); C07K16/1018 (US); (+) C12N7/00 (US); G01N33/56983 (US); C12N2760/16122 (EP,US); C12N2760/16133 (EP,US); C12N2760/16134 (EP,US); G01N2333/11 (US) (-)
	Former IPC [2013/39]	A61K38/00, C07K1/00, C12P21/06, C40B40/12
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/39]
Title	German:	AN DEN MENSCHEN ANGEPASSTE HA-POLYPEPTIDE, IMPFSTOFFE DARAUS UND INFLUENZA-BEHANDLUNG DAMIT	[2013/39]
	English:	HUMAN-ADAPTED HA POLYPEPTIDES, VACCINES, AND INFLUENZA TREATMENT	[2013/39]
	French:	TRAITEMENT ET/OU CARACTÉRISATION DE LA GRIPPE ; POLYPEPTIDES HA ADAPTÉS À L'HOMME	[2013/39]
Entry into regional phase	19.04.2013	National basic fee paid
	19.04.2013	Search fee paid
	19.04.2013	Designation fee(s) paid
	19.04.2013	Examination fee paid
Examination procedure	19.04.2013	Examination requested [2013/39]
	12.10.2015	Amendment by applicant (claims and/or description)
	22.12.2016	Despatch of a communication from the examining division (Time limit: M04)
	03.05.2017	Application deemed to be withdrawn, date of legal effect [2017/40]
	01.06.2017	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/40]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 22.12.2016
Fees paid	Renewal fee
	27.09.2013	Renewal fee patent year 03
	29.09.2014	Renewal fee patent year 04
	28.09.2015	Renewal fee patent year 05
	27.09.2016	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A] - KARTHIK VISWANATHAN ET AL, "Glycans as receptors for influenza pathogenesis", GLYCOCONJUGATE JOURNAL, KLUWER ACADEMIC PUBLISHERS, BO, (20100824), vol. 27, no. 6, ISSN 1573-4986, pages 561 - 570, XP019818965 [A] 1-15 * page 563, column right - page 568; figure 1 *
		[A] - SHRIVER Z ET AL, "Context-Specific Target Definition in Influenza A Virus Hemagglutinin-Glycan Receptor Interactions", CHEMISTRY AND BIOLOGY, CURRENT BIOLOGY, LONDON, GB, vol. 16, no. 8, doi:10.1016/J.CHEMBIOL.2009.08.002, ISSN 1074-5521, (20090828), pages 803 - 814, (20090827), XP026521536 [A] 1-15 * page 809 - page 812; figure 6 * DOI: http://dx.doi.org/10.1016/j.chembiol.2009.08.002
		[A] - M Matrosovich ET AL, "Influenza A virus isolate A/Albany/6/58 (H2N2)) hemagglutinin gene, pa - Nucleotide - NCBI", (20000523), URL: http://www.ncbi.nlm.nih.gov/nuccore/AF270723?%3Fdb=nucleotide, (20150303), XP055173512 [A] 1-15 * the whole document *
	International search	[Y]US2008241918 (SASISEKHARAN ET AL.);
		[A]US2009081193 (SASISEKHARAN ET AL.);
		[A]US2010061990 (SASISEKHARAN ET AL.);
		[Y] - PAPPAS ET AL., "Receptor Specificity and Transmission of H2N2 Subtype Viruses Isolated from the Pandemic of 1957.", PLOS ONE., (201006), vol. 5, no. 6, page E11158, XP055136851 DOI: http://dx.doi.org/10.1371/journal.pone.0011158
		[A] - "HEMAGGLUTININ PRECURSOR", SWISS-PROT, (20061128), XP055150695
		[A] - MATROSOVICH ET AL., "Early Alterations of the Receptor-Binding Properties of H1, H2, and H3 Avian Influenza Virus Hemagglutinins after Their Introduction into Mammals.", J VIROL., (2000), vol. 74, no. 18, pages 8502 - 8512, XP002503150 DOI: http://dx.doi.org/10.1128/JVI.74.18.8502-8512.2000
		[XP] - VISWANATHAN ET AL., "Determinants of Glycan Receptor Specificity of H2N2 Influenza A Virus Hemagglutinin.", PLOS ONE., (201010), vol. 5, no. 10, page E13768, XP055136249 DOI: http://dx.doi.org/10.1371/journal.pone.0013768

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p